Related Experiment Video

Updated: Jun 6, 2026

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Marketing paediatric influenza vaccination: results of a major metropolitan trial

Paul G Van Buynder1, Dale Carcione, Vince Rettura

  • 1School of Population Health, University of Western Australia, Perth, Western Australia, Australia. pjvb@iinet.net.au

Influenza and Other Respiratory Viruses
|December 9, 2010
PubMed

Insights

A targeted media campaign significantly increased influenza vaccination coverage in young children, leading to fewer flu cases. This approach effectively addressed parental concerns and boosted immunization rates in Western Australia.

Area of Science:

  • Pediatric Public Health
  • Vaccinology
  • Epidemiology

Background:

  • A cluster of fatal pediatric influenza cases prompted a vaccination initiative for children aged 6-59 months in Western Australia.
  • Anticipated parental hesitancy and low overseas vaccination rates necessitated a strategic marketing campaign to maximize uptake.

Purpose of the Study:

  • To evaluate the effectiveness of a targeted media campaign in increasing pediatric influenza vaccination coverage.
  • To reduce influenza incidence in young children through enhanced immunization.

Main Methods:

  • A multi-channel marketing campaign was implemented, utilizing newspapers, posters, radio, direct outreach to childcare centers, and websites.
  • Post-vaccination surveys were conducted to ascertain parental reasons for vaccination decisions.

Main Results:

  • The campaign achieved higher influenza vaccination coverage rates than previously reported in similar studies.
  • A corresponding reduction in influenza notifications was observed in the targeted age group compared to prior seasons.

Conclusions:

  • Pediatric influenza vaccination is safe, effective, and crucial for reducing childhood morbidity and mortality.
  • Targeted media campaigns can successfully overcome barriers to vaccination by emphasizing influenza's severity and dispelling myths.
  • The program's success offers valuable insights for improving similar public health initiatives globally.
Abstract

More Related Videos

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...